rs202210195
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_014208.3(DSPP):āc.3221A>Gā(p.Asp1074Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0625 in 888,802 control chromosomes in the GnomAD database, including 6,034 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1074AAATAVIAVTAV?) has been classified as Likely benign.
Frequency
Consequence
NM_014208.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSPP | NM_014208.3 | c.3221A>G | p.Asp1074Gly | missense_variant | 5/5 | ENST00000651931.1 | NP_055023.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSPP | ENST00000651931.1 | c.3221A>G | p.Asp1074Gly | missense_variant | 5/5 | NM_014208.3 | ENSP00000498766 | P1 | ||
ENST00000506480.5 | n.323-47350T>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.183 AC: 21853AN: 119330Hom.: 3104 Cov.: 24
GnomAD3 exomes AF: 0.0847 AC: 8635AN: 102000Hom.: 1053 AF XY: 0.0801 AC XY: 4192AN XY: 52344
GnomAD4 exome AF: 0.0437 AC: 33655AN: 769358Hom.: 2921 Cov.: 155 AF XY: 0.0490 AC XY: 18727AN XY: 382046
GnomAD4 genome AF: 0.183 AC: 21872AN: 119444Hom.: 3113 Cov.: 24 AF XY: 0.179 AC XY: 10415AN XY: 58054
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at